Medicine and Dentistry
Adolescence
14%
Antigenicity
18%
Biological Marker
30%
Botulinum Toxin A
69%
Brain Dysfunction
16%
Cataract
14%
Cholinesterase
31%
Clinical Research
14%
Clostridium Botulinum Type A
28%
Communicable Disease
14%
COVID-19
41%
Demography
28%
Disability Adjusted Life Years
11%
Disease
46%
Disease Activity
28%
Disease Burden
9%
Disease Severity
18%
Ganglion
9%
Global Disease Burden
100%
Human Immunodeficiency Virus
11%
Injury
16%
Inner Plexiform Layer
9%
Leg
14%
Life Expectancy
28%
Liver Dysfunction
19%
Meningitis
15%
Mental Capacity
14%
Meta-Analysis
28%
Mortality
9%
Mortality Rate
19%
Multiple Sclerosis
42%
Neurologic Disease
25%
Neurological System
14%
Neuromyelitis Optica
14%
Neutralizing Antibody
28%
Optical Coherence Tomography
11%
Patient-Reported Outcome
28%
Penicillamine
12%
Population Research
13%
Prevalence
31%
Prognostication
14%
Refractive Error
14%
Retinal Nerve Fiber Layer
11%
Spasmodic torticollis
45%
Spinal Cord Injury
14%
Systematic Review
16%
Teriflunomide
14%
Toddlers
9%
Visual Impairment
13%
Wilson's Disease
85%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
10%
Botulinum Toxin A
12%
Brain Dysfunction
16%
Cataract
14%
Cerebrovascular Accident
10%
Cervical Dystonia
14%
Chelation Therapy
5%
Clinical Research
14%
Clostridium Botulinum Type A
28%
Communicable Disease
14%
Comorbidity
6%
Diabetic Neuropathy
7%
Disease
70%
Disease Activity
16%
Disease Exacerbation
19%
Fumaric Acid Dimethyl Ester
14%
Global Disease Burden
100%
Growth Disorder
7%
Health Hazard
7%
HIV
6%
Inflammatory Disease
14%
Injury
13%
Life Expectancy
14%
Liver Dysfunction
19%
Low Birth Weight
7%
Meningitis
17%
Mortality Rate
6%
Multiple Sclerosis
60%
Myelooptic Neuropathy
14%
Neurologic Disease
25%
Pandemic
16%
Penicillamine
12%
Premature Labor
7%
Prevalence
35%
Refraction Error
14%
Retrospective Study
17%
Spinal Cord Injury
14%
Teriflunomide
14%
Thrombocyte Activating Factor
7%
Visual Impairment
13%
Wilson's Disease
42%
